Skip to main content
HLB bioStep Co.,Ltd. logo

HLB bioStep Co.,Ltd. — Investor Relations & Filings

Ticker · 278650 ISIN · KR7278650007 KO Professional, scientific and technical activities
Open in API
Filings indexed 326 across all filing types
Latest filing 2023-03-22 Audit Report / Informat…
Country KR South Korea
Listing KO 278650

About HLB bioStep Co.,Ltd.

http://hlbbiostep.com/en/

HLB bioStep Co.,Ltd. is a non-clinical Contract Research Organization (CRO) that provides a range of testing services to pharmaceutical companies and bio ventures. The company's core services support new drug development and include efficacy testing, pharmacokinetic/toxicokinetic (PK/TK) studies, and toxicology evaluations. A key area of specialization is veterinary medicine; HLB bioStep is an institution approved to conduct non-clinical tests and clinical trials for veterinary drugs. It also offers consulting services for regulatory approval procedures. The company utilizes various platform technologies, such as cell-enzyme-based screening and xenograft assays, and provides a comprehensive 'One-Stop Service' that leverages its experience in building laboratory facilities.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal announcement of the submission of an audit report ('감사보고서 제출') by the company '노터스'. It contains key financial data tables (consolidated and separate financial statements, audit opinions, and capital status) typically found in a regulatory filing that notifies the market of the completion and submission of the audit. While it contains financial data, it is a summary disclosure provided to the regulatory body (KRX) rather than the full, multi-page annual report document itself. Therefore, it is classified as a Regulatory Filing (RNS). FY 2022
2023-03-22 Korean
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the fiscal year 2022, submitted by Knotus Co., Ltd. to the Financial Services Commission and the Korea Exchange. It contains comprehensive financial information, business descriptions, governance details, and management analysis, which is the standard format for an Annual Report in the South Korean regulatory context (equivalent to a 10-K). FY 2022
2023-03-22 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의), which includes the date, location, and agenda items (such as financial statement approval, board compensation, and articles of incorporation changes). This is a standard proxy solicitation document used to inform shareholders of an upcoming meeting and request their participation/votes. Therefore, it falls under the Proxy Solicitation & Information Statement category.
2023-03-15 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) regarding the company's decision to hold its Annual General Meeting on a 'concentrated date' (a date when many companies hold their meetings). It explains the scheduling rationale and compliance status with the KOSDAQ Association's voluntary compliance program. Since it is a specific regulatory disclosure regarding meeting logistics rather than the meeting materials themselves or a proxy statement, it falls under the general regulatory filing category.
2023-03-15 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Knotus Co., Ltd. It contains the agenda for the 11th Annual General Meeting, including items such as financial statement approval, board/management information, and voting procedures. While it contains financial data, it is primarily a proxy solicitation document sent to shareholders to inform them of the meeting and request their votes (including electronic voting instructions). This fits the definition of a Proxy Solicitation & Information Statement.
2023-03-15 Korean
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from a Korean company (Notus) regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. This action directly results in the issuance of new shares, which changes the company's capital structure. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'SHA' category.
2023-03-14 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.